- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07927530
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Patients With Type 2 Diabetes
Efficacy of Ultrasound-Guided Thoracolumbar Fascia Injection in the Treatment of Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
This prospective, randomized, controlled clinical trial aims to evaluate the efficacy of ultrasound-guided thoracolumbar fascia (TLF) injection as an adjunct to standard conservative treatment in patients with type 2 diabetes mellitus and chronic nonspecific low back pain.
A total of 60 patients aged 18-65 years, diagnosed with type 2 diabetes mellitus for at least one year and experiencing chronic nonspecific low back pain for at least three months, will be enrolled. Eligible participants will be randomly assigned to two groups. The intervention group will receive ultrasound-guided thoracolumbar fascia injection in addition to standard conservative treatment, while the control group will receive standard conservative treatment alone, consisting of patient education and a structured exercise program.
Clinical assessments will be performed at baseline and at 1 and 3 months after treatment. Treatment outcomes will include pain intensity measured using the Numeric Rating Scale (NRS), functional disability assessed using the Oswestry Disability Index (ODI), pressure pain threshold (PPT) measured by algometry, and analgesic consumption.
Thoracolumbar fascia thickness will be measured using ultrasonography at baseline to investigate its potential association with treatment response. Diabetes-related characteristics, including HbA1c levels, diabetes duration, and peripheral neuropathy status, will also be recorded.
The primary objective is to determine whether adding ultrasound-guided thoracolumbar fascia injection to standard conservative treatment provides greater improvement in pain intensity and functional disability compared with standard conservative treatment alone. The study will also explore whether baseline thoracolumbar fascia thickness and diabetes-related characteristics are associated with clinical outcomes.
Panoramica dello studio
Stato
Condizioni
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Hatice Zehra FERHATLAR, MD
- Numero di telefono: 05367387869
- Email: haticezehraferhatlar@gmail.com
Luoghi di studio
-
-
Istanbul
-
Küçükçekmece, Istanbul, Turchia (Türkiye), 34307
- Reclutamento
- Kanuni Sultan Suleyman Training and Research Hospital
-
Contatto:
- Hatice Zehra FERHATLAR, MD
- Numero di telefono: 05367387869
- Email: haticezehraferhatlar@gmail.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
**Inclusion Criteria:**
- Age between 18 and 65 years.
- Diagnosis of type 2 diabetes mellitus for at least 1 year.
- Chronic low back pain lasting at least 3 months.
- Nonspecific or mechanical low back pain.
- Baseline pain intensity of ≥4 on the Numeric Rating Scale (NRS).
- Pain or tenderness on palpation over the thoracolumbar fascia region.
- Willingness to participate in the study.
- Provision of written informed consent.
**Exclusion Criteria:**
- Radiculopathy or significant neurological deficits.
- Neurogenic claudication due to spinal stenosis.
- Spinal tumor or infection.
- History or presence of vertebral fracture.
- Inflammatory rheumatic disease.
- Spinal surgery within the previous 6 months.
- Injection in the lumbar region within the previous 3 months.
- Anticoagulant therapy or conditions contraindicating injection.
- Active infection at the injection site.
- Severe systemic disease, including advanced renal failure.
- Uncontrolled diabetic metabolic condition.
- Pregnancy.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Thoracolumbar Fascia Injection Group
|
A single ultrasound-guided thoracolumbar fascia injection will be performed with the patient in the prone position under aseptic conditions. Using an in-plane technique, a 22-gauge needle will be advanced into the middle layer of the thoracolumbar fascia between the quadratus lumborum and erector spinae muscles at the L4 level. Correct needle placement will be confirmed by hydrodissection using approximately 2 mL of local anesthetic. Subsequently, 10 mL of 0.25% bupivacaine and 40 mg of methylprednisolone acetate will be administered into the interfascial plane. Standard conservative treatment will consist of structured patient education and a home-based exercise program. The exercise program will include lumbopelvic and core stabilization exercises, abdominal and paraspinal muscle strengthening, hip muscle strengthening, lower extremity stretching, and aerobic activity as tolerated. Participants will receive instructions on correct exercise techniques, maintaining daily activities, and avoiding prolonged bed rest. The program will be recommended for regular home practice throughout the study period. |
|
Comparatore attivo: Standard Conservative Treatment Group
|
Standard conservative treatment will consist of structured patient education and a home-based exercise program. The exercise program will include lumbopelvic and core stabilization exercises, abdominal and paraspinal muscle strengthening, hip muscle strengthening, lower extremity stretching, and aerobic activity as tolerated. Participants will receive instructions on correct exercise techniques, maintaining daily activities, and avoiding prolonged bed rest. The program will be recommended for regular home practice throughout the study period. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Change in Low Back Pain Intensity Measured by the Numeric Rating Scale (NRS)
Lasso di tempo: Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Change in Functional Disability Measured by the Oswestry Disability Index (ODI)
Lasso di tempo: Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
|
Change in Pressure Pain Threshold (PPT) Measured by Algometry
Lasso di tempo: Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
|
Change in Analgesic Consumption During Follow-up
Lasso di tempo: Baseline to Month 3
|
Baseline to Month 3
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Ahiskalioglu A, Yayik AM, Celik EC, Aydin ME, Uzun G. Ultrasound guided modified Thoracolumbar Interfascial Plane block for low back pain management. J Clin Anesth. 2019 May;54:138-139. doi: 10.1016/j.jclinane.2018.11.010. Epub 2018 Nov 28. No abstract available.
- Okmen BM, Okmen K. Effectiveness of the Ultrasound-Guided Interfascial Injection Applied in Addition to Physical Therapy Applications in Chronic Low Back Pain: A Quasi-Experimental Study. Eurasian J Med. 2024 Feb;56(1):56-60. doi: 10.5152/eurasianjmed.2024.23286.
- Lv Y, Wu J, Xu Y, Pu S, Li C, Du D. A novel approach to ultrasound-guided L3-4 thoracolumbar fascia injection for chronic pain after spine surgery: a prospective pilot study. BMC Anesthesiol. 2025 May 15;25(1):243. doi: 10.1186/s12871-025-03046-6.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- TLF-DM-RCT-2026
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .